查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1736712

2026 年至 2032 年製藥廢棄物管理市場規模（按廢棄物類型、廢棄物性質、最終用戶和地區分類）

Pharmaceutical Waste Management Market Size By Waste Type, Nature of Waste, End-User & Region for 2026-2032
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

製藥廢棄物管理市場評估-2026-2032

由於人口成長和醫療設施擴張，全球範圍內產生的藥物廢棄物日益增多，已成為一個重大問題。人們越來越意識到不當藥物廢棄物處置帶來的環境和健康風險。為了減少此類危害，同時確保環境永續性，人們越來越重視適當的藥物廢棄物管理，這將推動市場規模在2024年突破16,623.5億美元，並在2032年達到約26,315.9億美元的估值。

此外，政府和環保組織對藥物廢棄物處置實施的嚴格規定和準則正在推動對有效藥物廢棄物管理解決方案的需求。為了減少藥物廢棄物的不利影響，監管機構越來越注重確保安全和無害環境的處置。此外，藥物廢棄物管理市場受到越來越多採用先進技術的推動，例如高溫焚燒、掩埋以及化學處理和高壓釜等非焚燒方法。這些方法有助於安全處置和銷毀藥物廢棄物，減少與不當處置相關的環境和健康問題。由於對藥物廢棄物管理的需求不斷成長，市場將從 2026 年到 2032 年以 5.91% 的複合年成長率成長。

製藥廢棄物管理市場定義/概述

藥物廢棄物管理是指對藥品生命週期內產生的各類藥物廢棄物進行安全有效的處置。這些廢棄物包括過期或未使用的藥品、受污染的包裝以及藥品生產、分銷和管理過程中使用的其他物品。藥物廢棄物管理的目標是減少因處置不當而造成的環境和健康問題，以及對人體的潛在危害。

藥物廢棄物管理用於各種環境，例如製藥廠、醫院、診所、藥局、研究機構等。這些組織產生大量的藥物廢棄物，包括過期和未使用的藥品、受污染的包裝、實驗室化學品等。適當的廢棄物管理對於滿足環境要求、減少污染和保護公眾健康至關重要。

醫療廢棄物的增加將如何推動醫藥廢棄物管理市場？

全球製藥業正在迅速擴張，導致廢棄物排放不斷增加。根據IQVIA人類數據科學研究所的數據，預計到2026年，全球醫藥支出將達到1.8兆美元，複合年成長率為3-6%。根據世界衛生組織（WHO）的數據，到2020年，全球藥品產量將從1985年的3,000億單位成長十倍，達到3兆單位以上。這種擴張直接導致需要有效處置的製藥廢棄物增加。

為了因應日益嚴重的環境問題，世界各國政府正在頒布更嚴格的藥品廢棄物處理法律。根據美國環保署 (EPA) 統計，美國超過 7,000 家醫療機構每年排放超過 14,000 噸危險藥品廢棄物。根據歐洲藥品管理局 (EMA) 統計，歐盟 (EU) 88% 的新藥申請需要進行環境風險評估，高於 2005 年的 10%。

此外，公眾對不當藥品處置帶來的環境和健康危害的認知不斷提高，這也推動了市場的成長。發表在《環境毒理學與化學》雜誌上的一項研究發現，93種最常見配方藥物中，88%的藥物在地表水、地下水和飲用水中都以微量存在。根據美國地質調查局的數據，80%的美國河流中含有微量藥物。這種認知促使人們開展更多妥善處置藥物的項目，例如美國緝毒局的“全國處方藥回收日”，僅在2021年10月就收集了744,082磅不需要的處方藥。

高資本投入會阻礙製藥廢棄物管理市場嗎？

成功管理藥物廢棄物所需的巨額資本支出是醫院、醫療機構和製藥公司面臨的一大障礙。這些機構必須投入大量資金，建立符合環保要求並減少污染的先進廢棄物管理系統。這些系統成本高昂，需要先進的技術來收集、處理和處置危險和非危險藥物廢棄物，這給這些機構的預算帶來了沉重的負擔。

藥物廢棄物管理所需的高昂資本成本，對小型醫療機構和製藥公司構成了進入壁壘，阻礙了市場擴張。小型企業無力負擔實施現代化廢棄物管理技術所需的高昂前期成本，因此選擇成本較低、效率較低的方案或錯誤的處置技術。這加劇了環境污染，危及公眾健康，與藥物廢棄物管理的目標背道而馳。

目錄

第1章 引言

  • 市場定義
  • 市場區隔
  • 調查時間表
  • 先決條件
  • 限制

第2章調查方法

  • 資料探勘
  • 二次研究
  • 初步研究
  • 專家建議
  • 品質檢查
  • 最終審核
  • 數據三角測量
  • 自下而上的方法
  • 自上而下的方法
  • 調查流程
  • 資料來源

第3章執行摘要

  • 全球製藥廢棄物管理市場概覽
  • 全球製藥廢棄物管理絕對商機
  • 全球製藥廢棄物管理市場吸引力（按地區）
  • 全球製藥廢棄物管理市場（按地區）分析
  • 全球製藥廢棄物管理市場（按廢棄物類型）
  • 全球製藥廢棄物管理市場（按廢棄物類型）
  • 全球製藥廢棄物管理市場（按最終用戶分類）
  • 未來市場機會
  • 全球市場區隔

第4章 市場展望

  • 全球製藥廢棄物管理市場展望
  • 市場促進因素
    • 政府擴大採取適當措施處理藥品
    • 戰後嬰兒潮世代的崛起
  • 限制因素
    • 缺乏對藥品不當處置影響的認知
    • 廢棄物處理成本高昂
  • 可能性
    • 世界各地研究和開發活動活性化。
  • COVID-19 對全球製藥廢棄物管理市場的影響
  • 宏觀經濟分析
  • 波特五力分析
    • 新進入者的威脅
    • 替代品的威脅
    • 供應商的議價能力
    • 買家的議價能力
    • 競爭對手之間的競爭強度
  • 價值鏈分析

第5章廢棄物類型市場

  • 概述
  • 危險醫藥廢棄物
  • 無害醫藥廢棄物

第6章廢棄物類型市場

  • 概述
  • 非處方藥廢棄物
  • 不受管制的處方藥
  • 管制藥物
  • 危險藥物

第7章 終端用戶市場

  • 概述
  • 醫院
  • 製藥公司
  • 製藥和生物技術公司
  • 診所和診所
  • 其他

第8章 區域市場

  • 概述
  • 北美洲
    • 北美市場概述
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲市場概述
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 亞太市場概述
    • 中國
    • 印度
    • 日本
    • 其他亞太地區
  • 拉丁美洲
    • 拉丁美洲市場概述
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 中東和非洲
    • 中東和非洲市場概述
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 南非
    • 其他中東和非洲地區

第9章 競爭態勢

  • 概述
  • 各公司市場排名分析
  • 區域足跡
  • 公司在各行業的足跡

第10章 公司簡介

  • STERICYCLE
  • DANIELS HEALTH
  • WASTE MANAGEMENT INC.
  • CARDINAL HEALTH, INC.
  • COVANTA HOLDING CORPORATION
  • US ECOLOGY, INC.
  • BIOMEDICAL WASTE SOLUTION LLC
  • BECTON, DICKINSON AND COMPANY
  • STRYKER
  • 醫療廢棄物服務
Product Code: 40255

Pharmaceutical Waste Management Market Valuation - 2026-2032

The increasing volume of pharmaceutical waste generated globally owing mostly to population growth and improved healthcare facilities is a major concern. People are becoming more aware of the environmental and health risks associated with inappropriate pharmaceutical waste disposal. There is an increasing emphasis on proper pharmaceutical waste management to reduce these dangers while also ensuring environmental sustainability by enabling the market to surpass a revenue of USD 1662.35 Billion valued in 2024 and reach a valuation of around USD 2631.59 Billion by 2032.

Furthermore, severe rules and guidelines enforced by governments and environmental organizations governing pharmaceutical waste disposal are driving up the demand for effective pharmaceutical waste management solutions. To reduce the negative consequences of pharmaceutical waste, regulatory organizations are increasingly focusing on ensuring its safe and environmentally appropriate disposal. In addition, the pharmaceutical waste management market is being driven by the increasing adoption of advanced technologies such as high-temperature incineration, landfilling, and non-incineration methods such as chemical treatments and autoclaves. These methods facilitate the safe disposal and destruction of pharmaceutical waste lowering the environmental and health concerns associated with inappropriate disposal. The growing need for pharmaceutical waste management by enabling the market to grow at a CAGR of 5.91% from 2026 to 2032.

Pharmaceutical Waste Management Market: Definition/ Overview

Pharmaceutical waste management is the safe and efficient disposal of various types of pharmaceutical waste created during the lifecycle of pharmaceutical products. This waste consists of expired or unused medications, contaminated packaging, and other items used in the production, distribution, and administration of pharmaceuticals. The goal of pharmaceutical waste management is to reduce the environmental and health concerns associated with inappropriate disposal as well as potential harm to human health.

Pharmaceutical waste management is used in a variety of settings including pharmaceutical production plants, hospitals, clinics, pharmacies, and research organizations. These organizations generate a substantial amount of pharmaceutical waste which includes expired or unused pharmaceuticals, contaminated packaging, and laboratory chemicals. Proper waste management is critical to meeting environmental requirements, reducing pollution, and protecting public health.

How Does the Increasing Volume of Healthcare Waste Drive the Pharmaceutical Waste Management Market?

The global pharmaceutical business is rapidly expanding, resulting in increased waste output. According to the IQVIA Institute for Human Data Science, global pharmaceutical spending is expected to reach USD 1.8 Trillion by 2026, increasing at a 3-6% compound annual growth rate. According to the World Health Organization (WHO), global pharmaceutical production has expanded from 300 billion Standard Units in 1985 to more than 3 trillion Standard Units in 2020, a 10-fold increase. This expansion directly adds to the increasing volume of pharmaceutical waste that requires effective disposal.

Governments around the world are enacting harsher laws for pharmaceutical waste disposal in response to growing environmental concerns. According to the Environmental Protection Agency (EPA), over 7,000 healthcare facilities in the United States generate over 14,000 tons of hazardous pharmaceutical waste each year. According to the European Medicines Agency (EMA), environmental risk evaluations are now needed for 88% of new drug applications in the European Union, up from 10% in 2005, resulting in increased demand for proper waste management solutions.

Furthermore, the growing public awareness of the environmental and health dangers connected with inappropriate medication disposal is propelling market growth. A study published in Environmental Toxicology and Chemistry discovered that 88% of the 93 most often prescribed medications can be found in trace levels in surface, ground, and drinking water. According to the US Geological Survey, 80% of US streams contain trace levels of human pharmaceuticals. This awareness is prompting additional programs for proper disposal, such as the United States Drug Enforcement Administration's National Prescription Drug Take Back Day, which gathered 744,082 pounds of unneeded prescription medicines in October 2021 alone.

How Does the High Capital Investment Hamper the Pharmaceutical Waste Management Market?

The large capital expenditure necessary for successful pharmaceutical waste management presents a substantial barrier for hospitals, healthcare institutes, and pharmaceutical corporations. These organizations must devote significant financial resources to creating sophisticated waste management systems that comply with environmental requirements and reduce pollution. The high expense of these systems which involve advanced technologies for collecting, processing, and disposing of both hazardous and non-hazardous pharmaceutical waste put a burden on these institutions' budgets.

The high capital requirements for pharmaceutical waste management stifle market expansion by acting as a barrier to entry for smaller healthcare facilities and pharmaceutical corporations. Smaller businesses are unable to afford the large upfront expenses associated with deploying modern waste management technology and instead choose cheaper, less effective options or incorrect disposal techniques. This increases environmental contamination and endangers public health contradicting the goals of pharmaceutical waste management.

Category-Wise Acumens

How Do Increased Procedures Related to Chronic Diseases Drive the Hazardous Pharmaceutical Waste?

The hazardous segment is estimated to dominate the pharmaceutical waste management market. Chronic diseases such as cancer, diabetes, cardiovascular disease, and respiratory disorders frequently necessitate extensive and long-term medical interventions such as surgeries, chemotherapy, radiation therapy, and medication. These treatments produce a large amount of hazardous medical waste which includes contaminated sharps, chemotherapeutic medications, pathological waste, and infectious materials.

As the global frequency of chronic diseases increases due to reasons such as aging populations, sedentary lifestyles, and unhealthy dietary habits, so does the volume of hazardous medical waste generated. The increasing number of healthcare operations associated with chronic diseases is likely to have a major impact on the hazardous waste segment of the medical waste management market. Healthcare facilities such as hospitals, clinics, and specialized treatment centers must consequently establish appropriate waste management systems to properly and efficiently manage the rising volume of hazardous medical waste.

Furthermore, proper treatment of hazardous medical waste created during chronic disease operations is critical to maintaining public health and environmental safety. The regulatory rules for waste management are being edited and tightened to address the issues provided by the growing volume of hazardous medical waste. As a result, healthcare facilities are rapidly investing in innovative waste management technology and solutions to comply with these laws while reducing the environmental and health concerns connected with hazardous medical waste.

How do the Increasing Awareness and New Technologies Drive the Hospitals in the Market?

Hospitals accounted for the largest market share due to rising awareness campaigns and the introduction of new technologies. The healthcare industry is becoming more conscious of the necessity of effective medical waste management for maintaining public health and environmental safety. As a result, there has been an increase in awareness campaigns, conferences, and training sessions centered on new technology and best practices for medical waste management.

Furthermore, the introduction of new medical waste management technologies is critical to boosting the growth of the hospital and diagnostic laboratory markets. Healthcare facilities are progressively using advanced technologies to manage medical waste safely and efficiently, such as autoclaving, microwave treatment, steam sterilization, and chemical disinfection. These technologies have various benefits such as improved waste sterilization, less environmental impact, and cheaper operational costs. As a result, hospitals, diagnostic laboratories, and other healthcare facilities are expanding their investments in modern technologies to improve waste management.

Furthermore, the increasing emphasis on regulatory compliance and environmental sustainability is encouraging healthcare organizations to invest in innovative medical waste management technologies. Regulatory bodies are enforcing stricter norms and regulations for medical waste management and treatment to reduce environmental pollution and public health threats. As a result, rising awareness and the introduction of new technologies are likely to propel the end-user segment particularly hospitals and diagnostic laboratories into the medical waste management market.

Country/Region-wise Acumens

How will the Increasing Adoption of Pharmaceutical Waste Management Services Drive the Market in North America?

North America is estimated to dominate the pharmaceutical waste management market during the forecast period. North America, particularly the United States, has one of the most severe regulatory regimes for managing pharmaceutical waste. According to the US Environmental Protection Agency (EPA), over 7,000 healthcare facilities in the United States generate over 14,000 tons of hazardous pharmaceutical waste each year. The Resource Conservation and Recovery Act (RCRA) and the Hazardous Waste Pharmaceuticals Rule, which were enacted in 2019, established tight standards for pharmaceutical waste treatment, resulting in market growth in this region.

Furthermore, North Americans are becoming more conscious of the proper disposal of unused or expired drugs. The Drug Enforcement Administration's (DEA) National Prescription Drug Take Back Day has witnessed a considerable turnout. The DEA stated in 2021 that their Take Back Day programs had gathered a total of 15,989,566 pounds (more than 7,995 tons) of prescription medicines since the program's commencement in 2010. This increased awareness and engagement in such programs is generating demand for pharmaceutical waste management services in the region.

Will the Growing Prevalence of Chronic Diseases Boost the Market in the European Region?

Europe region is estimated to exhibit substantial growth within the market during the forecast period. Europe has enacted stringent laws for pharmaceutical waste treatment, resulting in market growth. The European Commission's 2020 pharmaceutical plan intends to minimize the environmental effect of medicines by 30% by 2030. According to the European Medicines Agency (EMA), 88% of new medicine applications in the European Union now include an environmental risk assessment, up from 10% in 2005. This regulatory climate compels pharmaceutical businesses and healthcare facilities to invest in effective waste management solutions.

Furthermore, Europe has a high incidence of pharmaceutical use, which can be attributed in part to its aging population. According to Eurostat data, the proportion of people aged 65 and over is expected to rise from 20.3% in 2019 to 29.4% by 2050. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), the European pharmaceutical market is estimated to be worth €213.4 billion in 2020. This high consumption rate, along with an aging population that normally requires more prescriptions, creates a substantial amount of pharmaceutical waste that must be properly managed.

Competitive Landscape

The pharmaceutical waste management market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations focus on innovating their product line to serve the vast population in diverse regions.

Some of the prominent players operating in the pharmaceutical waste management market include:

Cardinal Health

Covanta Holding Corporation

US Ecology, Inc.

Stericycle

BioMedical Waste Solution LLC

Dickinson and Company

Waste Management, Inc.

Daniels Health

Sharps Compliance, Inc.

Stryker

Becton

Latest Developments

In February 2021, Cardinal Health WaveMark(TM) Supply Management & Workflow Solutions partnered with HIMSS Analytics(R), a Certified Organization of the Clinically Integrated Supply Outcomes Model (CISOM), to help healthcare systems optimize and benchmark their progress in clinical and operational supply chains.

In February 2023, EcoSteris announced the development of a cutting-edge medical waste plant in Summerville, creating a unique and creative footprint in the business.

In May 2021, UPS Healthcare and Stericycle formed an ongoing relationship to manage medical waste reverse logistics, including trash classification and disposal. UPS and Stericycle hope to provide comprehensive logistical support to the healthcare industry as a result of their collaboration.

Pharmaceutical Waste Management Market, By Category

  • Type of Waste:
  • Over the counter Waste
  • Non-controlled Prescription Drugs
  • Controlled Drugs
  • Hazardous Drugs
  • Nature of Waste:
  • Hazardous Pharmaceutical Waste
  • Non-hazardous Pharmaceutical Waste
  • End User:
  • Hospitals
  • Pharmacies
  • Pharmaceutical & Biotechnology Companies
  • Clinics & Physicians' Offices
  • Region:
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 MARKET DEFINITION
  • 1.2 MARKET SEGMENTATION
  • 1.3 RESEARCH TIMELINES
  • 1.4 ASSUMPTIONS
  • 1.5 LIMITATIONS

2 RESEARCH METHODOLOGY

  • 2.1 DATA MINING
  • 2.2 SECONDARY RESEARCH
  • 2.3 PRIMARY RESEARCH
  • 2.4 SUBJECT MATTER EXPERT ADVICE
  • 2.5 QUALITY CHECK
  • 2.6 FINAL REVIEW
  • 2.7 DATA TRIANGULATION
  • 2.8 BOTTOM-UP APPROACH
  • 2.9 TOP-DOWN APPROACH
  • 2.1 RESEARCH FLOW
  • 2.11 DATA SOURCES

3 EXECUTIVE SUMMARY

  • 3.1 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET OVERVIEW
  • 3.2 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT ABSOLUTE MARKET OPPORTUNITY
  • 3.3 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET ATTRACTIVENESS, BY REGION
  • 3.4 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET GEOGRAPHICAL ANALYSIS (CAGR %)
  • 3.5 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE (USD MILLION)
  • 3.6 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE (USD MILLION)
  • 3.7 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER (USD MILLION)
  • 3.8 FUTURE MARKET OPPORTUNITIES
  • 3.9 GLOBAL MARKET SPLIT

4 MARKET OUTLOOK

  • 4.1 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET OUTLOOK
  • 4.2 MARKET DRIVERS
    • 4.2.1 INCREASING GOVERNMENT INITIATIVES FOR PROPER DISPOSAL OF MEDICATIONS
    • 4.2.2 INCREASING NUMBERS OF THE BOOMER GENERATION
  • 4.3 RESTRAINTS
    • 4.3.1 LACK OF AWARENESS ABOUT THE IMPACTS OF IMPROPER DISPOSAL OF MEDICATIONS
    • 4.3.2 HIGH COSTS ASSOCIATED WITH THIS WASTE MANAGEMENT
  • 4.4 OPPORTUNITIES
    • 4.4.1 INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES ACROSS THE GLOBE TO SUPPORT
  • 4.5 IMPACT OF COVID19 ON GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET
  • 4.6 MACROECONOMIC ANALYSIS
  • 4.7 PORTER'S FIVE FORCES ANALYSIS
    • 4.7.1 THREAT OF NEW ENTRANTS
    • 4.7.2 THREAT OF SUBSTITUTES
    • 4.7.3 BARGAINING POWER OF SUPPLIERS
    • 4.7.4 BARGAINING POWER OF BUYERS
    • 4.7.5 INTENSITY OF COMPETITIVE RIVALRY
  • 4.8 VALUE CHAIN ANALYSIS

5 MARKET, BY NATURE OF WASTE

  • 5.1 OVERVIEW
  • 5.2 HAZARDOUS PHARMACEUTICAL WASTE
  • 5.3 NON-HAZARDOUS PHARMACEUTICAL WASTE

6 MARKET, BY TYPE OF WASTE

  • 6.1 OVERVIEW
  • 6.2 OVER THE COUNTER WASTE
  • 6.3 NON-CONTROLLED PRESCRIPTION DRUGS
  • 6.4 CONTROLLED DRUGS
  • 6.5 HAZARDOUS DRUGS

7 MARKET, BY END USER

  • 7.1 OVERVIEW
  • 7.2 HOSPITALS
  • 7.3 PHARMACIES
  • 7.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 7.5 CLINICS & PHYSICIANS' OFFICE
  • 7.6 OTHERS

8 MARKET, BY GEOGRAPHY

  • 8.1 OVERVIEW
  • 8.2 NORTH AMERICA
    • 8.2.1 NORTH AMERICA MARKET SNAPSHOT
    • 8.2.2 U.S.
    • 8.2.3 CANADA
    • 8.2.4 MEXICO
  • 8.3 EUROPE
    • 8.3.1 EUROPE MARKET SNAPSHOT
    • 8.3.2 GERMANY
    • 8.3.3 U.K.
    • 8.3.4 FRANCE
    • 8.3.5 ITALY
    • 8.3.6 SPAIN
    • 8.3.7 REST OF EUROPE
  • 8.4 ASIA PACIFIC
    • 8.4.1 ASIA PACIFIC MARKET SNAPSHOT
    • 8.4.2 CHINA
    • 8.4.3 INDIA
    • 8.4.4 JAPAN
    • 8.4.5 REST OF ASIA PACIFIC
  • 8.5 LATIN AMERICA
    • 8.5.1 LATIN AMERICA MARKET SNAPSHOT
    • 8.5.2 BRAZIL
    • 8.5.3 ARGENTINA
    • 8.5.4 REST OF LATIN AMERICA
  • 8.6 MIDDLE EAST AND AFRICA
    • 8.6.1 MIDDLE EAST AND AFRICA MARKET SNAPSHOT
    • 8.6.2 UAE
    • 8.6.3 SAUDI ARABIA
    • 8.6.4 SOUTH AFRICA
    • 8.6.5 REST OF MIDDLE EAST AND AFRICA

9 COMPETITIVE LANDSCAPE

  • 9.1 OVERVIEW
  • 9.2 COMPANY MARKET RANKING ANALYSIS
  • 9.3 COMPANY REGIONAL FOOTPRINT
  • 9.4 COMPANY INDUSTRY FOOTPRINT

10 COMPANY PROFILES

  • 10.1 STERICYCLE
    • 10.1.1 COMPANY OVERVIEW
    • 10.1.2 COMPANY INSIGHTS
    • 10.1.3 PRODUCT BENCHMARKING
    • 10.1.4 WINNING IMPERATIVES
    • 10.1.5 CURRENT FOCUS & STRATEGIES
    • 10.1.6 THREAT FROM COMPETITION
    • 10.1.7 SWOT ANALYSIS
  • 10.2 DANIELS HEALTH
    • 10.2.1 COMPANY OVERVIEW
    • 10.2.2 COMPANY INSIGHTS
    • 10.2.3 PRODUCT BENCHMARKING
    • 10.2.4 WINNING IMPERATIVES
    • 10.2.5 CURRENT FOCUS & STRATEGIES
    • 10.2.6 THREAT FROM COMPETITION
    • 10.2.7 SWOT ANALYSIS
  • 10.3 WASTE MANAGEMENT INC.
    • 10.3.1 COMPANY OVERVIEW
    • 10.3.2 COMPANY INSIGHTS
    • 10.3.3 PRODUCT BENCHMARKING
    • 10.3.4 WINNING IMPERATIVES
    • 10.3.5 CURRENT FOCUS & STRATEGIES
    • 10.3.6 THREAT FROM COMPETITION
    • 10.3.7 SWOT ANALYSIS
  • 10.4 CARDINAL HEALTH, INC.
    • 10.4.1 COMPANY OVERVIEW
    • 10.4.2 COMPANY INSIGHTS
    • 10.4.3 SEGMENT BREAKDOWN
    • 10.4.4 PRODUCT BENCHMARKING
  • 10.5 COVANTA HOLDING CORPORATION
    • 10.5.1 COMPANY OVERVIEW
    • 10.5.2 COMPANY INSIGHTS
    • 10.5.3 PRODUCT BENCHMARKING
  • 10.6 US ECOLOGY, INC.
    • 10.6.1 COMPANY OVERVIEW
    • 10.6.2 COMPANY INSIGHTS
    • 10.6.3 PRODUCT BENCHMARKING
  • 10.7 BIOMEDICAL WASTE SOLUTION LLC
    • 10.7.1 COMPANY OVERVIEW
    • 10.7.2 COMPANY INSIGHTS
    • 10.7.3 PRODUCT BENCHMARKING
  • 10.8 BECTON, DICKINSON AND COMPANY
    • 10.8.1 COMPANY OVERVIEW
    • 10.8.2 COMPANY INSIGHTS
    • 10.8.3 SEGMENT BREAKDOWN
    • 10.8.4 PRODUCT BENCHMARKING
  • 10.9 STRYKER
    • 10.9.1 COMPANY OVERVIEW
    • 10.9.2 COMPANY INSIGHTS
    • 10.9.3 PRODUCT BENCHMARKING
  • 10.10 MEDICAL WASTE SERVICE
    • 10.10.1 COMPANY OVERVIEW
    • 10.10.2 COMPANY INSIGHTS
    • 10.10.3 PRODUCT BENCHMARKING

LIST OF TABLES

  • TABLE1 MOST FREQUENTLY USED PHARMACEUTICALS THAT ARE DETECTED IN WASTEWATERS.
  • TABLE 2 PROJECTED REAL GDP GROWTH (ANNUAL PERCENTAGE CHANGE) OF KEY COUNTRIES
  • TABLE 3 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 4 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 5 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 6 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY GEOGRAPHY, 2022-2030 (USD MILLION)
  • TABLE 7 NORTH AMERICA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 8 NORTH AMERICA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 9 NORTH AMERICA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE10 NORTH AMERICA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE11 U.S. PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE12 U.S. PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE13 U.S. PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE14 CANADA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE15 CANADA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE16 CANADA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE17 MEXICO PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE18 MEXICO PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE19 MEXICO PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 20 EUROPE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 21 EUROPE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 22 EUROPE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 23 EUROPE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 24 GERMANY PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 25 GERMANY PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 26 GERMANY PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 27 U.K. PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 28 U.K. PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 29 U.K. PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 30 FRANCE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 31 FRANCE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 32 FRANCE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 33 ITALY PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 34 ITALY PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 35 ITALY PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 36 SPAIN PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 37 SPAIN PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 38 SPAIN PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 39 REST OF EUROPE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 40 REST OF EUROPE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 41 REST OF EUROPE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 42 ASIA PACIFIC PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 43 ASIA PACIFIC PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 44 ASIA PACIFIC PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 45 ASIA PACIFIC PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 46 CHINA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 47 CHINA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 48 CHINA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 49 INDIA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 50 INDIA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 51 INDIA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 52 JAPAN PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 53 JAPAN PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 54 JAPAN PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 55 REST OF ASIA PACIFIC PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 56 REST OF ASIA PACIFIC PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 57 REST OF ASIA PACIFIC PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 58 LATIN AMERICA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 59 LATIN AMERICA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)

LIST OF FIGURES

  • FIGURE1 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET SEGMENTATION
  • FIGURE 2 RESEARCH TIMELINES
  • FIGURE 3 DATA TRIANGULATION
  • FIGURE 4 MARKET RESEARCH FLOW
  • FIGURE 5 DATA SOURCES
  • FIGURE 6 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET GEOGRAPHICAL ANALYSIS, 2023-30
  • FIGURE 7 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE (USD MILLION)
  • FIGURE 8 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE (USD MILLION)
  • FIGURE 9 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER (USD MILLION)
  • FIGURE10 FUTURE MARKET OPPORTUNITIES
  • FIGURE11 NORTH AMERICA DOMINATED THE MARKET IN 2021
  • FIGURE12 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET OUTLOOK
  • FIGURE13 ANNUAL INCREASE IN THE RETIRED U.S. BABY BOOMER POPULATION (IN MILLIONS)
  • FIGURE14 ANNUAL R&D SPENDING BY PHRMA MEMBER FIRMS (IN BILLIONS OF 2019 DOLLARS)
  • FIGURE15 PORTER'S FIVE FORCES ANALYSIS
  • FIGURE16 VALUE CHAIN ANALYSIS
  • FIGURE17 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE
  • FIGURE18 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE
  • FIGURE19 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER
  • FIGURE 20 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY GEOGRAPHY, 2022-2030 (USD MILLION)
  • FIGURE 21 U.S. PHARMACEUTICAL R&D EXPENDITURE, 2000-2019 (USD MILLION)
  • FIGURE 22 U.S. MARKET SNAPSHOT
  • FIGURE 23 CANADA MARKET SNAPSHOT
  • FIGURE 24 MEXICO MARKET SNAPSHOT
  • FIGURE 25 PHARMACEUTICAL PRODUCTION IN EUROPE, 2019 (EUROS MILLION)
  • FIGURE 26 GERMANY MARKET SNAPSHOT
  • FIGURE 27 U.K. MARKET SNAPSHOT
  • FIGURE 28 FRANCE MARKET SNAPSHOT
  • FIGURE 29 ITALY MARKET SNAPSHOT
  • FIGURE 30 SPAIN MARKET SNAPSHOT
  • FIGURE 31 REST OF EUROPE MARKET SNAPSHOT
  • FIGURE 32 CHINA MARKET SNAPSHOT
  • FIGURE 33 INDIA MARKET SNAPSHOT
  • FIGURE 34 JAPAN MARKET SNAPSHOT
  • FIGURE 35 REST OF ASIA PACIFIC MARKET SNAPSHOT
  • FIGURE 36 BRAZIL MARKET SNAPSHOT
  • FIGURE 37 ARGENTINA MARKET SNAPSHOT
  • FIGURE 38 REST OF LATIN AMERICA MARKET SNAPSHOT
  • FIGURE 39 UAE MARKET SNAPSHOT
  • FIGURE 40 SAUDI ARABIA MARKET SNAPSHOT
  • FIGURE 41 SOUTH AFRICA MARKET SNAPSHOT
  • FIGURE 42 REST OF MIDDLE EAST AND AFRICA MARKET SNAPSHOT
  • FIGURE 43 KEY STRATEGIC DEVELOPMENTS
  • FIGURE 44 STERICYCLE: COMPANY INSIGHT
  • FIGURE 45 STERICYCLE: SWOT ANALYSIS
  • FIGURE 46 DANIELS HEALTH: COMPANY INSIGHT
  • FIGURE 47 DANIELS HEALTH: SWOT ANALYSIS
  • FIGURE 48 WASTE MANAGEMENT INC.: COMPANY INSIGHT
  • FIGURE 49 WASTE MANAGEMENT INC.: SWOT ANALYSIS
  • FIGURE 50 CARDINAL HEALTH, INC.: COMPANY INSIGHT
  • FIGURE 51 CARDINAL HEALTH, INC.: SEGMENT BREAKDOWN
  • FIGURE 52 COVANTA HOLDING CORPORATION: COMPANY INSIGHT
  • FIGURE 53 US ECOLOGY, INC.: COMPANY INSIGHT
  • FIGURE 54 BIOMEDICAL WASTE SOLUTION LLC: COMPANY INSIGHT
  • FIGURE 55 BECTON, DICKINSON AND COMPANY: COMPANY INSIGHT
  • FIGURE 56 CARDINAL HEALTH, INC.: SEGMENT BREAKDOWN
  • FIGURE 57 STRYKER: COMPANY INSIGHT
  • FIGURE 58 MEDICAL WASTE SERVICE: COMPANY INSIGHT